 |
|
|
| |
Safety and Efficacy of Twice Daily versus Every 8 Hour Telaprevir with Peginterferon/Ribavirin in Patients with Cirrhosis
|
| |
| |
Reported by Jules Levin
EASL 2013 April 24-28 Amsterdam
Yves Horsmans,1 Robert S Brown Jr,2 Maria Buti,3 Kosh Agarwal,4 William Sievert,5 Ewa Janczewska,6 Stefan Zeuzem,7 Lisa Nyberg,8 Christophe Hezode,9 Mario Rizzetto,10 Raymundo Parana,11Sandra De Meyer,12 Ralph De Masi,13 Donghan Luo,13 James Witek13
1Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium; 2Columbia University College of Physicians and Surgeons, New York, NY, USA; 3Hospital Valle Hebron and Ciberehd del Instituto Carlos III, Barcelona, Spain; 4Kings College Hospital, London, UK; 5Monash Medical Centre and Monash University, Melbourne, Australia; 6Outpatients Clinic for Hepatology, Myslowice, Poland; 7Johann Wolfgang Goethe University Medical Center, Frankfurt am Main, Germany; 8Kaiser Permanente, San Diego, CA, USA; 9Hôpital Henri Mondor, Créteil, France; 10University of Torino, Torino, Italy; 11Medical School, Federal University of Bahia, Bahia, Brazil; 12Janssen Infectious Diseases BVBA, Beerse, Belgium; 13Janssen Research & Development LLC, Titusville, NJ, USA
|
| |
|
|
|
|
|
